DIABLO and cancer: Following the discovery of a potent antagonist of XIAP [38], small molecule mimetics of smac/DIABLO (smac-mimetics; SMs) were developed to overcome the survival benefits of IAP upregulation in cancer cells, through their antagonism of IAP activity and promotion of tumour cell death [39,40,41,42].